[{"status": "Terminated", "city": "Latham", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70807", "recalling_firm": "Fallon Wellness Pharmacy, L.L.C.", "address_1": "1057 Troy Schenectady Rd", "address_2": "N/A", "postal_code": "12110-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D-1075-2015", "product_description": "Hydroxocobalamin 1) 1000mcg/mL, 2) 5mg/0.5mL, 3) 5000mcg/0.2mL injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110", "product_quantity": "70 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150317", "center_classification_date": "20150512", "termination_date": "20180605", "report_date": "20150520", "code_info": "Lot#: a) 02092015@59, Exp 4/10/15; b) 02122015@49, Exp 4/13/15; c) 02132015@44, Exp 4/14/15; d) 02192015@34, Exp 4/20/15", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1256-2015", "product_description": "Amlodipine Besylate Tablets, 10 mg Tablets,   Packaged as A) 90 Count Bottles (NDC: 64679-423-01) and B) 1000 Count Bottles (NDC: 64679-423-02, Rx Only.  Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 152,164 Bottles and B) 50,991 Bottles.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: DM12975, Expiry: 10/31/2015; Lot #: DM12976, Expiry: 10/31/2015; Lot #: DM12977, Expiry:10/31/2015;  Lot #: DM12986, Expiry: 10/31/2015; Lot #: DM13259. Expiry: 10/31/2015; Lot #: DM13269, Expiry: 10/31/2015; Lot #: DM13270, Expiry: 11/30/2015; Lot #: DM13275, Expiry: 11/30/2015;  Lot #: DM13339, Expiry: 11/30/2015; Lot #: DM13341, Expiry: 11/30/2015; Lot #: DM13369, Expiry: 11/30/2015; Lot #: DM13370, Expiry: 11/30/2015; Lot #: DN10088, Expiry: 12/31/2015; Lot #: DN10099, Expiry: 12/31/2015; Lot #: DN10939, Expiry: 3/31/2016; Lot #: DN10940, Expiry: 3/31/2016.  B) Lot #: DM11422, Expiry: 5/31/2015; Lot #: DM11423, Expiry: 5/31/2015; Lot #: DM11424, Expiry: 5/31/2015; Lot #: DM11425, Expiry: 5/31/2015; Lot #: DM12634, Expiry: 9/30/2015; Lot #: DM12635; Expiry: 9/30/2015; Lot #: DM12660, Expiry: 9/30/2015; Lot #: DM12661, Expiry: 9/30/2015; Lot #: DM12662, Expiry: 9/30/2015; Lot #: DM12663, Expiry: 9/30/2015; Lot #: DM12673, Expiry: 9/30/2015; Lot #: DM12674, Expiry: 9/30/2015; Lot #: DM12684, Expiry: 9/30/2015; Lot #: DM12685, Expiry: 9/30/2015; Lot #: DM12985, Expiry: 10/31/2015; Lot #: DM13162, Expiry: 10/31/2015; Lot #: DM13163, Expiry: 10/31/2015; Lot #: DM13195, Expiry: 10/31/2015; Lot #: DM13196, Expiry: 10/31/2015; Lot #: DM13222, Expiry: 10/31/2015; Lot #: DM13223, Expiry: 10/31/2015; Lot #: DM13271, Expiry: 11/30/2015; Lot #: DM13272, Expiry: 11/30/2015; Lot #: DM13273, Expiry: 11/30/2015; Lot #: DM13274, Expiry: 11/30/2015; Lot #: DM13281, Expiry: 11/30/2015; Lot #: DM13282, Expiry: 11/30/2015; Lot #: DM13296, Expiry: 11/30/2015; Lot #: DM13297, Expiry: 11/30/2015: Lot #: DM13393, Expiry: 11/30/2015; Lot #: DM13394, Expiry: 11/30/2015; Lot #: DM13395, Expiry: 11/30/2015; Lot #: DM13403, Expiry: 11/30/2015; Lot #: DM13404, Expiry: 11/30/2015; Lot #: DM13415, Expiry: 11/30/2015; Lot #: DM13429, Expiry: 11/30/2015; Lot #: DN10077, Expiry: 12/31/2015; Lot #: DN10078, Expiry: 12/31/2015; Lot #: DN10079, Expiry: 12/31/2015; Lot #: DN10080, Expiry: 12/31/2015; Lot #: DN10081, Expiry: 12/31/2015; Lot #: DN10100, Expiry: 12/31/2015; Lot #: DN10104, Expiry: 12/31/2015; Lot #: DN10105, Expiry: 12/31/2015, Lot #: DN10336, Expiry: 12/31/2015; Lot #: DN10342, Expiry: 12/31/2015; Lot #: DN10343, Expiry: 12/31/2015; Lot #: DN10344, Expiry: 12/31/2015; Lot #: DN10355, Expiry: 12/31/2015; Lot #: DN10356, Expiry: 12/31/2015; Lot #:   DN10811, Expiry: 2/29/2016; Lot #: DN10812, Expiry: 2/29/2016; Lot # DN10830, Expiry: 2/29/2016; Lot #: DN10874, Expiry: 2/29/2016; Lot #: DN10875, Expiry: 2/29/2016; Lot #: DN10876, Expiry: 2/29/2016; Lot #: DN10890, Expiry: 2/29/2016; Lot #: DN10891, Expiry: 2/29/2016; Lot #: DN10938, Expiry: 3/31/2016; Lot #: DN10956, Expiry: 3/31/2016."}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0293-2016", "product_description": "Voriconazole Solution (1%(10 mg/mL), 15 mL dropper bottle; For Topical Ophthalmic Use, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-2815-10", "product_quantity": "2 dropper bottles", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20150209@40 BUD: 9/16/2015"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0418-2024", "product_description": "PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112.", "product_quantity": "10,017 syringes, expanded 2579 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223045040 Exp 11/13/23, 1223046397 Exp 01/06/24, 1223046505 Exp 01/10/24, 1223047254 Exp 02/08/24, 1223047436 Exp 02/15/24, 1223047938 Exp 03/13/24, 1223049150 Exp 05/02/24, 1223049300 Exp 05/09/24,  Expanded Lot #: 1223048569, Exp 04/06/2024; 1223049600, Exp 05/19/2024", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as one of the following drugs:  BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD68010_1, EXP: 5/28/2014;  THIORIDAZINE HCL, Tablet, 50 mg, NDC 00378061601, Pedigree: AD73525_28, EXP: 5/30/2014.", "address_2": "", "product_quantity": "63 Tablets", "code_info": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes:   Pedigree: AD68010_4, EXP: 5/28/2014;  Pedigree: AD73525_40, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00574010603.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-954-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77191", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0909-2017", "product_description": "Potassium PHOSphate added to 0.9% Sodium Chloride, 7.5 mMol 100 mL Bag, Service Code 2K5298, NDC# 61553-0298-48, Total Volume 100.00 mL incorrectly labeled as 102.50 mL, Rx Only, PharMEDium Services, LLC, 12620 W. Airport Blvd #130, Sugar Land, TX 74478", "product_quantity": "192 bags", "reason_for_recall": "Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.", "recall_initiation_date": "20170217", "center_classification_date": "20170612", "termination_date": "20170613", "report_date": "20170621", "code_info": "Lot Numbers:  163640146S, 3/30/2017; 170020187S, 4/3/2017; 170100120S, 4/11/2017; 170200117S, 4/23/2017; 170340009S, 5/6/2017"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020988"], "brand_name": ["PROTONIX"], "generic_name": ["PANTOPRAZOLE SODIUM"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0008-0923", "0008-4001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PANTOPRAZOLE SODIUM"], "rxcui": ["283669", "885257"], "spl_id": ["3d86f8c0-bb9c-4a12-88cf-7ce2bd97178b", "f8aaf9b3-59bb-4fb0-bd74-8a8f3bf353db"], "spl_set_id": ["51e4144a-489e-436c-609a-39305f8f56ba", "f39b3e7d-39d2-4c8a-9974-4ab885241880"], "package_ndc": ["0008-0923-51", "0008-0923-60", "0008-0923-55", "0008-4001-01", "0008-4001-10", "0008-4001-25", "00008-0941-01", "0008-0941-03"], "is_original_packager": [true], "unii": ["6871619Q5X"]}, "product_type": "Drugs", "event_id": "75871", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0516-2017", "product_description": "PROTONIX I.V. (pantoprazole sodium) for Injection, Equivalent to 40 mg pantoprazole per vial, For I.V. infusion only, Rx Only, Distributed by Wyeth Pharmaceuticals Inc, A subsidiary of Pfizer Inc, Philadelphia, PA 19101, Under license from Takeda GmbH, D78467 Konstanz, Germany, MADE IN FRANCE; packaged in A) Pfizer Injectables, 1 vial per carton (NDC 0008-0923-51) in a) bundles of 10 unit cartons (NDC 0008-0923-55) and b) 25 x 40 mg Vials per carton (NDC 0008-0923-60); B) NOVAPLUS, 1 vial per carton (NDC 00008-0941-01) in 25 x 40 mg Vials per carton (NDC 0008-0941-03); and C) PREMIERPro Rx, 1 vial per carton (NDC 0008-4001-01) in a) bundles of 10 unit cartons (NDC 0008-4001-10) and b) 25 x 40 mg Vials per carton (NDC 0008-4001-25).", "product_quantity": "582,165 vials", "reason_for_recall": "Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.", "recall_initiation_date": "20161122", "center_classification_date": "20170310", "termination_date": "20180622", "report_date": "20170322", "code_info": "Lot #: A) a) 325449, Exp 12/16; b) N97969, N69175, N69177, Exp 03/17; N95727, Exp 04/17; B) M51076, Exp 11/16; and C) a) 317364, Exp 11/16; b) N73763, Exp 03/17"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-642-2015", "product_description": "Doxycycline Hyclate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "335420 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0096-2015", "product_description": "Lidocaine (PF) 1% injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "20 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08152014@33, Exp 9/14/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Mason", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63661", "recalling_firm": "Procter & Gamble Co", "address_1": "8700 Mason Montgomery Rd", "address_2": "N/A", "postal_code": "45040-9462", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-069-2013", "product_description": "Vicks NyQuil Cold & Flu, Nighttime Relief, 12 FL OZ bottle, Dist. by Proctor and Gamble, Cincinnati, OH 45040. NDC 37000-808-12", "product_quantity": "17,532 bottles", "reason_for_recall": "Labeling Illegible: Portions of the product labeling in the area of the dosing directions, the warnings & other information sections is obscured.", "recall_initiation_date": "20121108", "center_classification_date": "20121129", "termination_date": "20131223", "report_date": "20121205", "code_info": "Lot #2278171941, Exp. 09/14,  Lot #2282171981, Exp. 09/14 ."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "94602", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0518-2024", "product_description": "Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04", "product_quantity": "51,006 bottles", "reason_for_recall": "Defective container: lack of seal integrity.", "recall_initiation_date": "20240508", "center_classification_date": "20240529", "termination_date": "20250429", "report_date": "20240605", "code_info": "Lot #F305184, F305185, F305186, Exp 7/31/ 2025", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0214-2021", "product_description": "fentaNYL 100 mcg/2mL Injection for IV or IM Use, 2 mL Single Dose Syringe, CII, Rx Only,  SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095    barcode 70004020006", "product_quantity": "6710 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot #1220023109, BUD 1/25/2021;  1220023255, BUD 1/26/2021;  1220023256. BUD 1/26/2021;  1220023257, BUD 1/28/2021;  1220023334, BUD 2/2/2021 &  1220023518, BUD 2/8/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89798", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0688-2022", "product_description": "Halobetasol Propionate Ointment, 0.05%, Net Wt. 50 grams tube, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-033-50.", "product_quantity": "35,185 tubes", "reason_for_recall": "cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.", "recall_initiation_date": "20220315", "center_classification_date": "20220321", "termination_date": "20240617", "report_date": "20220330", "code_info": "Batch: 15128, Exp. 2/28/2022; 15721, Exp. 6/30/2022; 16171, Exp. 10/31/2022; 16819, Exp. 4/30/2023; 17124, Exp. 7/31/2023"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA090483"], "brand_name": ["AMLODIPINE AND VALSARTAN"], "generic_name": ["AMLODIPINE AND VALSARTAN"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-1721", "0378-1722", "0378-1723", "0378-1724"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "VALSARTAN"], "rxcui": ["722126", "722131", "722134", "722137"], "spl_id": ["97bfe7c1-7e4b-45a1-b045-ff48275f1488"], "spl_set_id": ["aa7e7d95-520a-461c-b1b3-e588aeb6a613"], "package_ndc": ["0378-1721-93", "0378-1722-93", "0378-1723-93", "0378-1724-93"], "is_original_packager": [true], "upc": ["0303781722933", "0303781723930", "0303781721936", "0303781724937"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0321-2019", "product_description": "Amlodipine and Valsartan Tablets, USP 10/160 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-1722-93.", "product_quantity": "76,516 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers: 3064085, 3066063,3069638,3069639"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212514"], "brand_name": ["AMPHOTERICIN B"], "generic_name": ["AMPHOTERICIN B"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["62756-233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["AMPHOTERICIN B"], "rxcui": ["967385"], "spl_id": ["59a4c568-88ae-41be-80bf-0c8c6805f9b8"], "spl_set_id": ["593cffa0-c305-48b6-8ec7-331e0ff91d2b"], "package_ndc": ["62756-233-01", "62756-233-02"], "is_original_packager": [true], "upc": ["0362756233010"], "nui": ["N0000175510", "N0000175498", "M0017172"], "pharm_class_epc": ["Lipid-based Polyene Antifungal [EPC]", "Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["7XU7A7DROE"]}, "product_type": "Drugs", "event_id": "94442", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0493-2024", "product_description": "Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01", "product_quantity": "11,016 vials", "reason_for_recall": "Out of specification for assay", "recall_initiation_date": "20240419", "center_classification_date": "20240508", "report_date": "20240515", "code_info": "Lot #: BAE0055A, BAE0056A, BAE0068A, Exp. Date 03/2026"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t12-13-2016@95, Exp 5/22/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 30/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 30mcg/30mg/1mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0746-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0155-2023", "product_description": "Sodium Chloride Ophthalmic Ointment, USP, 5%, Net Wt. 3.5 g (1/8 oz.) per tube,  Manufactured by:  Akorn, Inc., Lake Forest, IL 60045. NDC:  17478-622-35", "product_quantity": "524,506 tubes", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 0F69A, EXP 5/31/2023; 0G92B, 0G92A, EXP 6/30/2023; 0J69A, EXP 8/31/2023; 0K29A, 0K24A, EXP 9/30/2023; 0M93A, 0M92A, 0M92B, EXP 11/30/2023; 1B25A, EXP 1/31/2024; 1C74A, EXP 2/29/2024; 1E19A, EXP 4/30/2024; 1C77A, EXP 2/29/2024;"}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "9859 syringes", "code_info": "Lot: 169262 BUD: 1/8/2017, Lot: 169812 BUD: 1/19/2017", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Succinylcholine Chloride 200 mg/10 mL Injection Solution 10 mL (20 mg/mL) ,Single-Dose Syringe Injection Solution, For Slow IV Use Only ,Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207, NDC 52533-067-12", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0204-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090161"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Ltd"], "product_ndc": ["55111-533"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099563"], "spl_id": ["bbff7587-1b4e-6616-e6f5-689bc89e1aea"], "spl_set_id": ["2e35f833-1cf7-12eb-9567-7a191e32e138"], "package_ndc": ["55111-533-30", "55111-533-60", "55111-533-01", "55111-533-05", "55111-533-79", "55111-533-78"], "is_original_packager": [true], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "82085", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0507-2019", "product_description": "Divalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 India  NDC 55111-533-01", "product_quantity": "10,656 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification results observed for high dissolution.", "recall_initiation_date": "20190131", "center_classification_date": "20190215", "termination_date": "20230214", "report_date": "20190227", "code_info": "Lot #: C802676, Exp 03/20", "more_code_info": ""}, {"country": "United States", "city": "Saint Paul", "address_1": "2400 Pilot Knob Rd", "reason_for_recall": "Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 17C01-U07-036096, Exp. 5/1/2020", "center_classification_date": "20170503", "distribution_pattern": "Nationwide within US", "state": "MN", "product_description": "Zinc Oxide Paste 25%, 500 g, For Prescription Compounding, Fagron Inc.2400 Pilot Knob Rd, St. Paul, MN 55120m  NDC 51522-0694-5.", "report_date": "20170510", "classification": "Class III", "openfda": {}, "recalling_firm": "Fagron, Inc", "recall_number": "D-0695-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77018", "termination_date": "20170811", "more_code_info": "", "recall_initiation_date": "20170417", "postal_code": "55120-1118", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1159-2023", "product_description": "TRP Natural Eyes, Floaters Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-098-15.", "product_quantity": "18,171 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: DA001 EXP: 06/24; Lot: DA002 EXP: 11/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Kirkland", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "97292", "recalling_firm": "AEQUITA PHARMACY", "address_1": "12825 Ne 126th Pl", "address_2": "N/A", "postal_code": "98034-7721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MA", "recall_number": "D-0555-2025", "product_description": "Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.", "product_quantity": "170 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20250718", "center_classification_date": "20250801", "report_date": "20250813", "code_info": "All Lots within expiry.", "more_code_info": ""}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209167"], "brand_name": ["TADALAFIL"], "generic_name": ["TADALAFIL"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"], "product_ndc": ["51655-473"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TADALAFIL"], "rxcui": ["402019"], "spl_id": ["29f19810-bb83-bacd-e063-6394a90a97ce"], "spl_set_id": ["f3092f5a-b976-91ab-e053-2995a90a9b50"], "package_ndc": ["51655-473-54", "51655-473-87"], "original_packager_product_ndc": ["16729-372"], "nui": ["N0000175599", "N0000020026"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "unii": ["742SXX0ICT"]}, "product_type": "Drugs", "event_id": "91944", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "4838 Fletcher Ave Ste 1000", "address_2": "N/A", "postal_code": "46203-1642", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0553-2023", "product_description": "Tadalafil Tablets, USP 20 mg, packaged in a) 6-count bottles (NDC 51655-473-87), and b) 15-count bottles (NDC 51655-473-54), Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.", "product_quantity": "a)164 bottles; b) 198 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230316", "center_classification_date": "20230426", "report_date": "20230503", "code_info": "a) Lot #: F113892002, Exp. Date 08/31/2023; F113892201, Exp. Date 11/30/2023 b) Lot #: F113892001, Exp. Date 08/31/2023; F113892202, Exp. Date 11/30/2023; F113892203, Exp. Date 12/31/2023"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0206-2016", "product_description": "BIEST TD 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3) : PROG (Progesterone USP Micronized) : TESTO (Testosterone USP) W/V (weight/volume)  1.25:100:0.625 MG/ML Transdermal cream, dispensed in 10 mL prefilled, amber syringes, Rx only,The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "12 (10mL) syringes", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01122015:25@6, Exp 7/11/2015;   Lot # 03042015:64@14, Exp 8/31/2015"}, {"status": "Terminated", "city": "Salt Lake City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76951", "recalling_firm": "Isomeric Pharmacy Solution, LLC", "address_1": "2401 S Foothill Dr Ste D", "address_2": "N/A", "postal_code": "84109-1479", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0684-2017", "product_description": "Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1021, barcode 3 70285 10211 0.", "product_quantity": "1,951 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20170406", "center_classification_date": "20170426", "termination_date": "20170830", "report_date": "20170503", "code_info": "Lot #s: 10013, Exp 05/10/17; 10020, Exp 05/20/17; 10029, Exp 05/27/17; 11002, Exp 05/30/17; 11013, Exp 06/04/17."}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1179-2020", "product_description": "Bi-Est8:2/Progesterone/Testosterone 1.0/50 MG/.5MG/ML Cream 30 GM, tube Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 44639 Discard by: 11/28/2020", "more_code_info": ""}, {"status": "Ongoing", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213212"], "brand_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "generic_name": ["CARBIDOPA, LEVODOPA AND ENTACAPONE"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "product_ndc": ["16571-689", "16571-690", "16571-691", "16571-692", "16571-693", "16571-694"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CARBIDOPA", "ENTACAPONE", "LEVODOPA"], "rxcui": ["403850", "403851", "403852", "730988", "810083", "810090"], "spl_id": ["bb341ca1-04d3-4a71-b79d-824653aa58a3"], "spl_set_id": ["2f8e82d7-6baf-456a-b8c3-4fda6e317902"], "package_ndc": ["16571-689-01", "16571-690-01", "16571-691-01", "16571-692-01", "16571-693-01", "16571-694-01"], "is_original_packager": [true], "upc": ["0316571689019", "0316571692019", "0316571694013", "0316571690015", "0316571691012", "0316571693016"], "nui": ["N0000175754", "N0000175755", "N0000175756", "N0000175757", "N0000193220", "M0370111"], "pharm_class_epc": ["Aromatic Amino Acid Decarboxylation Inhibitor [EPC]", "Catechol-O-Methyltransferase Inhibitor [EPC]", "Aromatic Amino Acid [EPC]"], "pharm_class_moa": ["DOPA Decarboxylase Inhibitors [MoA]", "Catechol O-Methyltransferase Inhibitors [MoA]"], "pharm_class_cs": ["Amino Acids, Aromatic [CS]"], "unii": ["MNX7R8C5VO", "4975G9NM6T", "46627O600J"]}, "product_type": "Drugs", "event_id": "97768", "recalling_firm": "Rising Pharma Holding, Inc.", "address_1": "2 Tower Center Blvd Ste 1401", "address_2": "", "postal_code": "08816-1149", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0029-2026", "product_description": "Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01", "product_quantity": "2,064 100-count bottles", "reason_for_recall": "Product mix up:  complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).", "recall_initiation_date": "20251007", "center_classification_date": "20251016", "report_date": "20251022", "code_info": "Lot # CS25070, exp. date 03/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0183-2016", "product_description": "BIEST 80/20 : PROGEST : DHEA : TESTOST (Estriol USP Micronized (E3)/Estradiol (E2) Trit (Yellow): Progesterone USP: Dehydroepiandrosterone Micronized (DHEA): Testosterone Trit ) 2.5 : 25 : 2.5 : 0.1MG TROCHE, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "60 troches", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 12312014:91@6, Exp 3/31/2015"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1172-2019", "product_description": "Prostaglandin Quad with Atropine 10:30:1:0.15, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "5 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211751"], "brand_name": ["ESOMEPRAZOLE MAGNESIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-528", "69097-529"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM DIHYDRATE"], "rxcui": ["692576", "692578"], "spl_id": ["e64d9eeb-1821-4520-9325-8b006fec057f"], "spl_set_id": ["c1319da6-bf0d-4dd6-a713-1677bfbfbdae"], "package_ndc": ["69097-528-34", "69097-529-34"], "is_original_packager": [true], "unii": ["36H71644EQ"]}, "product_type": "Drugs", "event_id": "87038", "recalling_firm": "CIPLA", "address_1": "10 Independence Blvd", "address_2": "N/A", "postal_code": "07059-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0183-2021", "product_description": "Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059 NDC 69097-529-34", "product_quantity": "6,491 packets", "reason_for_recall": "Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline", "recall_initiation_date": "20201217", "center_classification_date": "20201230", "termination_date": "20221207", "report_date": "20210106", "code_info": "Lot #: KA00415, KA00416, Exp 11/2021"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0766-2020", "product_description": "QUADMIX FORTE 30MG/4MG/40MCG/400MCG/ML INJ in 1 mL vial Assurance Infusion (713) 533-8800", "product_quantity": "134 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 07222019@10 Exp. 01/18/2020; 06242019@19 Exp. 12/21/2019; 08132019@15 Exp. 02/09/2020; 10292019@22 Exp. 04/26/2020; 11272019@24 Exp. 01/22/2020; 09182019@18 Exp. 03/16/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "92249", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0756-2023", "product_description": "Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue Injection Only, Not for Intravenous Use, 1 mL Single Dose Vial, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd. Parenteral Unit, Ahmedabad 382213, India, Amneal Pharamceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1574-01.", "product_quantity": "69,239 vials", "reason_for_recall": "Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number 70121-1574-1.", "recall_initiation_date": "20230508", "center_classification_date": "20230519", "termination_date": "20240321", "report_date": "20230531", "code_info": "Lot Numbers: AP220481, Exp 09/2024; AP220536A, Exp 10/2024"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "4,280 bags", "code_info": "Lot #4/23/18 0101 81525P, 4/23/18 1020 81525P, BUD 6/22/2018;4/30/18 1123 81525P, 4/30/18 1311 81525P, BUD 6/29/2018;  5/1/18 3456 81525P, BUD 6/30/2018; 5/8/18 3213 81525P, BUD 7/7/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "NORepiNEPHrine 8 mg (norepinephrine Bitartrate (USP) 8 mg added to 5% Dextrose Inj. (USP) 250 mL. (Concentration 32 mcg/mL) Volume: 258 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-815-25", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0939-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as    PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: AD62829_18, EXP: 5/24/2014;  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD62834_4, EXP: 5/24/2014;  diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: W003513, EXP: 6/21/2014;  DOCUSATE SODIUM, Capsule, 250 mg,", "address_2": "", "product_quantity": "480 Tablets", "code_info": "guaiFENesin ER, Tablet, 600 mg has the following codes    Pedigree: AD62834_4, EXP: 5/24/2014;  Pedigree: AD62834_7, EXP: 5/24/2014;  Pedigree: W003514, EXP: 6/21/2014;  Pedigree: W003574, EXP: 6/24/2014;  Pedigree: W003850, EXP: 6/27/2014;  Pedigree: W003931, EXP: 6/28/2014;  Pedigree: AD46429_1, EXP: 5/15/2014;  Pedigree: AD73592_1, EXP: 5/31/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guaiFENesin ER Tablet, 600 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 63824000834", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-683-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0437-2019", "product_description": "Prednisolone and Bromfenac Ophthalmic Solution, 1%/0.09% Combo Drops 3 mL, Rx Only, Compounded Prescription, Promise Pharmacy 31818 US Hwy 19N, Palm Harbor FL 34684", "product_quantity": "167 3 ml bottles", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 09262018@6 BUD: 12/25/2018; 11052018@2 BUD: 2/3/2019"}, {"status": "Terminated", "city": "Missoula", "state": "MT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71275", "recalling_firm": "Montana Compounding Pharmacy", "address_1": "111 N Higgins Ave", "address_2": "N/A", "postal_code": "59802-4437", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MT and ND", "recall_number": "D-1123-2015", "product_description": "Hyaluronidase (RM ONLY), Injectable Solution, 150 U/mL, 10ML vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT", "product_quantity": "20/1 mL vials", "reason_for_recall": "Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection", "recall_initiation_date": "20150515", "center_classification_date": "20150609", "termination_date": "20161220", "report_date": "20150617", "code_info": "Lot 02062015:06@3, expiry date: 5/17/2015;  Lot 02272015:93@1, expiry date: 6/30/2015;  Lot 03252015:92@7, expiry date: 6/30/2015;  Lot 04162015:63@7, expiry date: 6/30/2015."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90405", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-1172-2022", "product_description": "Fluticasone Propionate Nasal Spray, USP, 50 mcg, 16 g net fill weight per amber glass bottle, Rx only, Manufactured by: HI-TECH PHARMACAL CO., INC., Amityville, NY 11701. NDC 50383-700-16", "product_quantity": "44,400 bottles", "reason_for_recall": "Defective container: defect prevents product from dispensing as intended.", "recall_initiation_date": "20220613", "center_classification_date": "20220630", "termination_date": "20240714", "report_date": "20220706", "code_info": "Lot #: 379073, 379079, Exp 9/30/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Northstar Rx LLC"], "product_ndc": ["16714-755", "16714-756", "16714-757", "16714-758", "16714-759", "16714-760", "16714-761"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["fc2fb27b-9a53-4df1-874e-bb2ed5157aef"], "spl_set_id": ["133a4b65-762b-4712-baba-2442546f0379"], "package_ndc": ["16714-755-01", "16714-756-01", "16714-757-01", "16714-758-01", "16714-759-01", "16714-760-01", "16714-761-01"], "is_original_packager": [true], "upc": ["0316714761015", "0316714758015", "0316714759012", "0316714757018", "0316714760018", "0316714755014", "0316714756011"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0239-2025", "product_description": "Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Glenmark Pharmaceuticals Ltd., Goa, India, NDC 16714-756-01.", "product_quantity": "119,040 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19233228, 19233227, Exp.: 7/2025; 19233757, Exp.: 8/2025; 19234229, Exp.: 9/2025; 19235090, Exp.: 11/2025; 19241471, Exp.:3/2026; 19242180, Exp.: 5/2026."}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1708-2019", "product_description": "SUCCINYLCHOLINE CHLORIDE 20MG/ML INJ SOL, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0129-10", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0541-2016", "product_description": "Phytonadione (Vitamin K) 1 mg/0.1mL Syringe, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "20 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"country": "United States", "city": "Oklahoma City", "address_1": "1005 SW 2nd St", "reason_for_recall": "Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.", "address_2": "", "product_quantity": "1,928,075 vials", "code_info": "Lot #s: 102814, 102914, 103014, 103114, Exp 10/16; 110314, 110414, 110514, 110614, 110714, 111014, Exp 11/16; 121014, 121114, 121214, 121514, Exp 12/16; 011415, 011515, 011615, 012015, 012115, Exp 01/17; 021315, 021715, 021815, 021915, 022015, Exp 02/17; 030415, 030515, 030615, 031015, 031715, Exp 03/17; 042415, 042815, 042915, 043015, Exp 04/17; 050115, 050515, 052815, 052915, Exp 05/17; 060315, 060415, 061615, 061715, Exp 06/17", "center_classification_date": "20160907", "distribution_pattern": "Nationwide", "state": "OK", "product_description": "Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY  10605.", "report_date": "20160914", "classification": "Class II", "openfda": {}, "recalling_firm": "Allergy Laboratories, Inc.", "recall_number": "D-1498-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "74883", "termination_date": "20170313", "more_code_info": "", "recall_initiation_date": "20160810", "postal_code": "73109-1006", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pine Brook", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76664", "recalling_firm": "Alvogen, Inc", "address_1": "10 Bloomfield Ave Bldg B Ste 2", "address_2": "N/A", "postal_code": "07058-9743", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0628-2017", "product_description": "Adalat CC (nifedipine) Extended Release Tablets 30 mg, 100-count bottles, Rx only,  Manufactured for Bayer Healthcare Bayer Healthcare Pharmaceuticals Inc. Whippany, NJ 07901 Manufactured in Germany, NDC 50419-701-05", "product_quantity": "N/A", "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib", "recall_initiation_date": "20170307", "center_classification_date": "20170404", "termination_date": "20171215", "report_date": "20170412", "code_info": "Lot #: BXH1P21A, Exp. 11/2017"}, {"status": "Terminated", "city": "Research Triangle Park", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA204063"], "brand_name": ["TECFIDERA"], "generic_name": ["DIMETHYL FUMARATE"], "manufacturer_name": ["Biogen Inc."], "product_ndc": ["64406-005", "64406-007", "64406-006"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIMETHYL FUMARATE"], "rxcui": ["1373483", "1373489", "1373491", "1373493", "1373497", "1373498"], "spl_id": ["521e4305-9450-42a4-881b-05946acaa8fa"], "spl_set_id": ["665d7e74-036c-5f68-5b67-ab84b9b49151"], "package_ndc": ["64406-007-03", "64406-005-01", "64406-006-02"], "is_original_packager": [true], "upc": ["0364406005015", "0364406005107", "0364406005084"], "unii": ["FO2303MNI2"]}, "product_type": "Drugs", "event_id": "85906", "recalling_firm": "Biogen MA Inc.", "address_1": "5000 Davis Dr", "address_2": "", "postal_code": "27709", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to wholesalers/distributors in KY, OH & MS.", "recall_number": "D-1381-2020", "product_description": "Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only, Manufactured by: Biogen Inc., Cambridge, MA 02142, NDC 64406-006-02", "product_quantity": "3,922 bottles", "reason_for_recall": "cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.", "recall_initiation_date": "20200623", "center_classification_date": "20200709", "termination_date": "20210211", "report_date": "20200715", "code_info": "Lot # SH0274, Exp 2/2022", "more_code_info": ""}, {"status": "Completed", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022006"], "brand_name": ["SABRIL"], "generic_name": ["VIGABATRIN"], "manufacturer_name": ["Lundbeck Pharmaceuticals LLC"], "product_ndc": ["67386-211"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VIGABATRIN"], "spl_id": ["70fa5544-3c5c-4401-98c6-dbb992b6a198"], "spl_set_id": ["a88ac1b4-e2c9-45c0-b321-4785902172e3"], "package_ndc": ["67386-211-65"], "is_original_packager": [true], "nui": ["N0000175753"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "unii": ["GR120KRT6K"]}, "product_type": "Drugs", "event_id": "92894", "recalling_firm": "Lundbeck LLC", "address_1": "6 Parkway North Blvd Ste 400", "address_2": "N/A", "postal_code": "60015-2522", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-1142-2023", "product_description": "Sabril (vigabatrin) for Oral Solution, 500 mg, 50 Packets, Rx only, Manufactured by: Patheon, Cincinnati, OH 45237, NDC 67386-211-65", "product_quantity": "10,543 cartons", "reason_for_recall": "Cross contamination with other products", "recall_initiation_date": "20230817", "center_classification_date": "20230829", "report_date": "20230906", "code_info": "Lot#: 3207333A, 3207334A, Exp 03/2027; 3214707A, 3214709A, 3214710A, Exp 02/2028 ."}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "78067", "recalling_firm": "Aidarex Pharmaceuticals LLC", "address_1": "595 N Smith Ave Ste B", "address_2": "N/A", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed to the state of CA and NV.", "recall_number": "D-1162-2017", "product_description": "Phentermine, USP Capsules, 15 mg, 30 count bottles, Rx only, Packaged By: Aidarex Pharmaceuticals, Corona, CA, MFG: KVK-TECH INC. Newtown. PA --- 33261-0361-30", "product_quantity": "35 bottles", "reason_for_recall": "Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test", "recall_initiation_date": "20170905", "center_classification_date": "20170913", "termination_date": "20191204", "report_date": "20170920", "code_info": "Batch 47262-2, 47262-3, exp 8/31/2017; 47262-4, exp 12/30/17, 47262-5, 47262-6, 47262-7, exp 12/31/17"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84527", "recalling_firm": "MPRX, Inc. dba Medical Park Pharmacy", "address_1": "8230 Elmbrook Dr Ste 600b", "address_2": "N/A", "postal_code": "75247-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "TX", "recall_number": "D-0813-2020", "product_description": "Progesterone E4M SR 100 mg capsules", "product_quantity": "3 bottles", "reason_for_recall": "Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.", "recall_initiation_date": "20191218", "center_classification_date": "20200129", "termination_date": "20221213", "report_date": "20200205", "code_info": "Lot: 61219:42 Use by: 03/24/2020"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93946", "recalling_firm": "Super Chill Products", "address_1": "827 6th Ave", "address_2": "", "postal_code": "10001-6305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0393-2024", "product_description": "Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl.oz. (10 mL) bottle, Distributed By Superchill Products, 827 6th Avenue, New York, New York 10001.", "product_quantity": "3,573 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240205", "center_classification_date": "20240321", "termination_date": "20240820", "report_date": "20240327", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90151", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "USA Nationwide", "recall_number": "D-1147-2022", "product_description": "medroxyPROGESTERone Acetate Injectable Suspension, USP, 25 x 1 mL Single-Dose Vial, 150 mg/mL, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Halol Baroda Highway, Halol-389 350, Gujarat India , NDC 16714-090-40 packaged in 25 count carton.", "product_quantity": "26892 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20220506", "center_classification_date": "20220610", "termination_date": "20230814", "report_date": "20220622", "code_info": "Lot#: HAC2074A, Exp Date 06/2023; HAC0163B, Exp Date 01/2023 & HAC1741A, Exp Date 04/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018609"], "brand_name": ["HEPARIN SODIUM IN SODIUM CHLORIDE"], "generic_name": ["HEPARIN SODIUM"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0424", "0338-0431", "0338-0433", "0338-0428"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["HEPARIN SODIUM"], "rxcui": ["1658690", "1658692"], "spl_id": ["68b37381-6db4-4ac0-ba6b-3204add02665"], "spl_set_id": ["0d929726-76c3-48fc-b4e7-fd06409f9fb3"], "package_ndc": ["0338-0431-03", "0338-0433-04", "0338-0424-18", "0338-0428-12"], "is_original_packager": [true], "unii": ["ZZ45AB24CA"]}, "product_type": "Drugs", "event_id": "71356", "recalling_firm": "Baxter Healthcare Corp", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1131-2015", "product_description": "Heparin Sodium and 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL --- NDC 0338-0431-03", "product_quantity": "145,350 containers", "reason_for_recall": "Subpotent Drug; out of specification results for heparin raw material", "recall_initiation_date": "20150603", "center_classification_date": "20150609", "termination_date": "20170314", "report_date": "20150617", "code_info": "Product  Code: 280953  Lots: N002998 and N003004 exp 12/31/15; and lot N003038 exp. 01/31/2016"}, {"country": "United States", "city": "Allegan", "address_1": "515 Eastern Ave", "reason_for_recall": "Subpotent; 12 month time point for the active ingredient Phenylephrine HCl.", "address_2": "", "product_quantity": "60,048 Blister packs", "code_info": "2 AE1549  Exp. 02/13", "center_classification_date": "20130322", "distribution_pattern": "Walmart Distribution Center in Bentonville, AR", "state": "MI", "product_description": "PE Daytime Cold/Flu LiqGel, Multi Symptom Relief, Acetaminophen/Dextromethorphan HBr/Phenylephrine HCL 325/10/5 mg gel caps  20 count blister pack, Distributed By: Wal-Mat Stores Inc., Bentonville, AR, 72716", "report_date": "20130403", "classification": "Class III", "openfda": {}, "recalling_firm": "L. Perrigo Co.", "recall_number": "D-216-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "64388", "termination_date": "20130912", "more_code_info": "", "recall_initiation_date": "20130218", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0446-2020", "product_description": "OCuSOFT Tetravisc Tetracaine HCl 0.5% Sterile Anesthetic, 5 mL, Mfd. for OCuSOFT, Inc. PO Box 429 Richmond, TX 77406-0429 Made in USA, NDC  54799-505-05", "product_quantity": "105609 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17232    8/19    17334    11/19    18249    10/20    19125    4/21"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "850 syringes", "code_info": "Lot #: 5/7/18 0301 2-80761S, BUD 6/21/2018; 5/9/18 0510 2-80761S, BUD 6/23/2018; 5/21/18 1807 80761S, BUD 7/15/2018.", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "NORepiNEPHrine Bitartrate, USP 160 mcg in 5% Dextrose, USP QS 10mL. Volume 10mL. Single dose syringe. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-807-61", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0959-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["NATURE MINT ANTICAVITY"], "generic_name": ["SODIUM MONOFLUOROPHOSPHATE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-131"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM MONOFLUOROPHOSPHATE"], "rxcui": ["545626"], "spl_id": ["25cae217-37ed-403c-8a97-acfae13ef681"], "spl_set_id": ["39e9c844-d2c2-4e3c-84c0-bdb767a03f7b"], "package_ndc": ["53247-131-01", "53247-131-02", "53247-131-03", "53247-131-04", "53247-131-05", "53247-131-06", "53247-131-07"], "is_original_packager": [true], "unii": ["C810JCZ56Q"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0440-2025", "product_description": "Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 2.75 OZ (78g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-05", "product_quantity": "160,848 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0032, B0047, B0048, B0055, B0056, Exp Date: 07/31/2026; B0102, B0103, B0104, B0105, B0106, B0107, Exp Date: 09/30/2026"}, {"status": "Terminated", "city": "Cleveland", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74138", "recalling_firm": "Bayer Health Care LLC", "address_1": "4207 Michigan Avenue Rd NE", "address_2": "N/A", "postal_code": "37323-5505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0977-2016", "product_description": "Coppertone SUNSCREEN LOTION, CLEARLY SHEER, BROAD SPECTRUM SPF 50, 5 FL OZ (147mL), OTC, Dist by: Bayer HealthCare LLC, Whippany, NJ 07981 --- NDC 11523-7391-1, UPC 00041100005762", "product_quantity": "37,512 bottles", "reason_for_recall": "Labeling; Product Contains Undeclared API (Oxybenzone)", "recall_initiation_date": "20160510", "center_classification_date": "20160609", "termination_date": "20161006", "report_date": "20160615", "code_info": "CV006V9, 2/2018"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0198-2023", "product_description": "Cholecalciferol (Vitamin D3) 100,000U/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221130@14", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0175-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.5MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "6 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1009092021:50 BUD: 03/08/2022; T1006302021:37 BUD: 12/27/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0408-2022", "product_description": "Mitomycin-C Sterile Ophthalmic Solution, Preservative Free, 0.32mg/0.8 mL (0.4mg/mL) 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma LLC, 856 Hercules Dr.  Colchester, VT 05446, NDC 05446-1009-01", "product_quantity": "163 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "11-2021-08@8 12/18/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077183"], "brand_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "generic_name": ["AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "product_ndc": ["55111-338", "55111-339", "55111-340", "55111-341"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "BENAZEPRIL HYDROCHLORIDE"], "rxcui": ["898342", "898350", "898353", "898356"], "spl_id": ["6fafdf6a-6153-9a62-1774-755f2bcf0cc2"], "spl_set_id": ["ca014f06-982c-6fe1-9948-a3701dd35d34"], "package_ndc": ["55111-338-30", "55111-338-01", "55111-338-05", "55111-339-30", "55111-339-01", "55111-339-05", "55111-340-30", "55111-340-01", "55111-340-05", "55111-341-30", "55111-341-01", "55111-341-05"], "is_original_packager": [true], "upc": ["0355111339014", "0355111340010"], "unii": ["864V2Q084H", "N1SN99T69T"]}, "product_type": "Drugs", "event_id": "62591", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "200 Somerset Corporate Blvd Fl 7th", "address_2": "N/A", "postal_code": "08807-2862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1434-2012", "product_description": "Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg,  500 Capsules, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-340-05", "product_quantity": "1656 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets.", "recall_initiation_date": "20120409", "center_classification_date": "20120731", "termination_date": "20130124", "report_date": "20120808", "code_info": "C201293  Exp Date 08/2013"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "48 units", "code_info": "Rx #'s:   0389566        0391189      0400011    0363726        0384953        0389818      0389944    0391513    0394424    0398045    0399810    0400508      0400659      0400899    0402416    0406767    0408616    0408784    0409002    0394645    0404250    0404253    0383078    0390794    0396149    0407773    0380431    0400011    0408013    0385258        0396543        0400011    0386991    0398045", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "HYDROXYPROGESTERONE CAPROATE 250MG/ML INJECTABLE 10 ML, 12 ML, 13 ML, 15 ML, 3 ML, 30 ML, 4 ML, 5 ML, 6 ML, 7 ML, 9 ML (11 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1544-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Indiana", "address_1": "625 Kolter Dr Ste 4", "reason_for_recall": "Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot #: A0A0253, Exp. 02/2019; Lot #: B0369427-112717, Exp. 08/2019", "center_classification_date": "20181114", "distribution_pattern": "1 vial was distributed to a medical facility in Mayville, NY.", "state": "PA", "product_description": "Metoprolol Tartrate Injection, USP 5mg/5mL, vials, Rx only, MFG: Claris Lifesciences Inc., North Brunswick, NJ 08902, NDC# 70518-0868-00", "report_date": "20181121", "classification": "Class III", "openfda": {}, "recalling_firm": "RemedyRepack Inc.", "recall_number": "D-0245-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81554", "termination_date": "20190205", "more_code_info": "", "recall_initiation_date": "20181026", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0658-2017", "product_description": "Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-006-06)", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 78801507001 to 78901612003, exp 6/22/2017 through 11/21/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91786", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0460-2023", "product_description": "Alprazolam Tablets, USP, 1 mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0706-01), b) 500-count bottle (NDC 51991-0706-05) and c) 1,000-count bottle (NDC 51991-0706-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Potential risk of Cross Contamination", "recall_initiation_date": "20230302", "center_classification_date": "20230310", "termination_date": "20240321", "report_date": "20230322", "code_info": "Lot # 5210645, exp. date 3/31/2023, 500's Bottle 5210646, exp. date 3/31/2023, 500's Bottle 5210647, exp. date 3/31/2023, 500's Bottle  5210648, exp. date 3/31/2023, 1000's Bottle 5210649, exp. date 3/31/2023, 1000's Bottle  5210831, exp. date 4/30/2023, 100's Bottle  5210832, exp. date 4/30/2023, 500's Bottle 5210833, exp. date 4/30/2023, 500's Bottle  5210834, exp. date 4/30/2023, 1000's Bottle 5210835, exp. date 4/30/2023, 1000's Bottle  5210905, exp. date 5/31/2023, 100's Bottle 5210906, exp. date 5/31/2023, 100's Bottle  5210907, exp. date 5/31/2023, 500's Bottle 5210908, exp. date 5/31/2023, 500's Bottle 5210909, exp. date 5/31/2023, 500's Bottle 5210965, exp. date 5/31/2023, 500's Bottle  5210997, exp. date 5/31/2023, 1000's Bottle 5210998, exp. date 5/31/2023, 1000's Bottle 5211175, exp. date 6/30/2023, 1000's Bottle  5211176, exp. date 6/30/2023, 500's Bottle 5211177, exp. date 6/30/2023, 500's Bottle 5211178, exp. date 6/30/2023, 500's Bottle 5211179, exp. date 6/30/2023, 500's Bottle 5211180, exp. date 6/30/2023, 500's Bottle 5211181, exp. date 6/30/2023, 500's Bottle 5211205, exp. date 7/31/2023, 500 s Bottle 5211206, exp. date 7/31/2023, 500's Bottle  5211227, exp. date 7/31/2023, 1000's Bottle  5211228, exp. date 7/31/2023, 100's Bottle  5211229, exp. date 7/31/2023, 1000's Bottle  5211334, exp. date 8/31/2024, 500's Bottle  5211335, exp. date 8/31/2024, 1000's Bottle  5211456, exp. date 8/31/2024 , 500's Bottle 5211457, exp. date 8/31/2024 , 500's Bottle 5211458, exp. date 8/31/2024, 500's Bottle  5211459, exp. date 9/30/2024, 1000's Bottle  5211727, exp. date 11/30/2024, 100's Bottle  5211730, exp. date 11/30/2024, 1000's Bottle 5220028, exp. date 12/31/2024, 1000's Bottle 5220029, exp. date 12/31/2024, 1000's Bottle  5220288, exp. date 2/28/2025, 100's Bottle"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1173-2019", "product_description": "Prostaglandin Tri-Mix 20:30:1, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "58 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0416-2017", "product_description": "Trimix Injectable 30 mg/1 mg/25 mcg/mL, 5 mL vial, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "7 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known lot code: 07192016@26."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; COENZYME Q-10, Capsule, 30 mg may be potentially mislabeled as    PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W002819, EXP: 6/7/2014.", "address_2": "", "product_quantity": "60 Capsules", "code_info": "COENZYME Q-10, Capsule, 30 mg has the following code    Pedigree: W002814, EXP: 6/7/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "COENZYME Q-10, Capsule, 30 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904501546", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-468-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77959", "recalling_firm": "Bella Pharmaceuticals, Inc.", "address_1": "3101 W Devon Ave", "address_2": "N/A", "postal_code": "60659-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within USA", "recall_number": "D-1148-2017", "product_description": "Mannitol 20%, 10 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.", "product_quantity": "10 vials", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20170815", "center_classification_date": "20170912", "termination_date": "20180423", "report_date": "20170920", "code_info": "Lot #: 070717ML, Exp. 1/7/18"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "7 Bags", "code_info": "All product compounded  between May 14, 2015 and May 27, 2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "TPN 3:1, 3000 mL Bags, Qty: 7, Base Formula Dextrose 70%, Travasol 10%, Intralipid 20%, Water for Inj; Electrolytes Famotidine, MgSO4, KCL, NaC, Zinc Cl; Vitamins, trace elements and medications Multitrace-4, Multi Vitamin, Vitamin K, Ascorbic Acid, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1159-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0883-2019", "product_description": "Dr. King's SafeCare Rx Procrastination, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955276029, NDC 57955-2761-2", "product_quantity": "95 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 091715C Exp. 09/18; 091316C Exp. 09/19"}, {"status": "Terminated", "city": "Johnson City", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207733"], "brand_name": ["NYSTATIN CREAM"], "generic_name": ["NYSTATIN CREAM"], "manufacturer_name": ["Crown Laboratories"], "product_ndc": ["0316-0221"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["NYSTATIN"], "rxcui": ["543546"], "spl_id": ["42ee71fd-bcfd-a17d-e063-6294a90ab4bb"], "spl_set_id": ["5a2b6fee-1437-0c3a-e053-2991aa0a3443"], "package_ndc": ["0316-0221-15", "0316-0221-30"], "is_original_packager": [true], "upc": ["0303160221156"], "nui": ["N0000175498", "M0017172"], "pharm_class_epc": ["Polyene Antifungal [EPC]"], "pharm_class_cs": ["Polyenes [CS]"], "unii": ["BDF1O1C72E"]}, "product_type": "Drugs", "event_id": "85833", "recalling_firm": "Crown Laboratories", "address_1": "349 Lafe Cox Dr", "address_2": "N/A", "postal_code": "37604-7469", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA.", "recall_number": "D-1338-2020", "product_description": "Nystatin Cream, USP 100,000 units per gram, 30 grams, Rx Only,  Manufactured and Distributed by: Crown Laboratories, Inc. Johnson City, TN 37604, NDC 0316-0221-30", "product_quantity": "62,274 tubes", "reason_for_recall": "Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.", "recall_initiation_date": "20200610", "center_classification_date": "20200624", "termination_date": "20211105", "report_date": "20200701", "code_info": "Lot: Y0378A, EXP 07/2021"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0239-2020", "product_description": "S-MANGANESE CHLORIDE 0.1MG/ML MDV SOLN, 10 ML vial, Red Mountain Compounding Rx", "product_quantity": "2x10 ml vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S05082019DT@01, Exp 9/8/19;  S05222019DH@03, Exp 9/22/19"}, {"status": "Ongoing", "city": "Bedminster", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203269"], "brand_name": ["RIZATRIPTAN BENZOATE"], "generic_name": ["RIZATRIPTAN BENZOATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-261", "67877-262"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIZATRIPTAN BENZOATE"], "rxcui": ["312840", "314209"], "spl_id": ["9fd3ccaa-ae93-475b-9591-5c4af70f51c5"], "spl_set_id": ["07e66554-bc85-4853-9f40-1249617630a9"], "package_ndc": ["67877-261-30", "67877-261-01", "67877-261-05", "67877-261-18", "67877-261-25", "67877-262-30", "67877-262-01", "67877-262-05", "67877-262-18", "67877-262-25"], "is_original_packager": [true], "upc": ["0367877261300"], "unii": ["WR978S7QHH"]}, "product_type": "Drugs", "event_id": "96770", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "135 Us Highway 202 206 Ste 15", "address_2": "N/A", "postal_code": "07921-2608", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0534-2025", "product_description": "Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ 07054, NDC 67877-262-18", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.", "recall_initiation_date": "20250709", "center_classification_date": "20250717", "report_date": "20250723", "code_info": "Lot 22143653, 22143675, Exp Date: July 2025; Lot 22144528, Exp Date: September 2025; Lot 22144977, Exp Date: November 2025; Lot 23140257, Exp Date: December 2025; Lot 23140999, Exp Date: Feb. 2026; Lot 23141900, 23142118, 23142120, 23142123, Exp Date: May 2026; Lot 23144563, 23144565, Exp Date: November 2026; Lot 24142623, Exp Date: May 2027;  Lot 24142624, 24142626, 24143469, Exp Date: Jun. 2027."}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0463-2019", "product_description": "Sermorelin, 15mg, injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "266 vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 07102018@4 BUD: 1/6/2019; 09142018@6 BUD: 3/13/2019; 10052018@4 BUD: 4/3/2019; 11062018@1 BUD: 5/5/2019"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "97103", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0518-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-15", "product_quantity": "82,159 bottles", "reason_for_recall": "Subpotent Drug:  Assay below the approved specification", "recall_initiation_date": "20250620", "center_classification_date": "20250714", "report_date": "20250723", "code_info": "Lot #D2300325, Exp Date: 01/31/2026; Lot #D2400536, Exp Date: 02/28/2026"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0598-2017", "product_description": "SULFUR 5% CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0969-2016", "product_description": "Thin and Slim Extreme Stack Fat Burner Dietary Supplement packaged in 90 capsule containers.  TSN Labs Inc., P.O. Box 38, Midvale, UT 84047, 1-800-769-7290, www.tsn2000.com", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "UPC 637687019133"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0368-2015", "product_description": "Ranitidine various strengths in syringes", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0055-2023", "product_description": "TALC, STERILE POWDER, 5 GM vial, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65995, BUD: 10/28/2022"}, {"status": "Terminated", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80359", "recalling_firm": "Eb5 Corporation", "address_1": "538 Sw 4th Ave", "address_2": "", "postal_code": "97204-2102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nation Wide in the USA.", "recall_number": "D-0908-2018", "product_description": "eb5 Skincare that Works. Age Spot Treatment. Skin Lightening Cream with 2% Hydroquinone. 177.4 ml / 6 fl oz carton containing a tube. Manufactured For: EB5 Corporation Portland, OR 97210 Carton Bar Code: 7 41099 00009 9", "product_quantity": "4,632 tubes", "reason_for_recall": "Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity", "recall_initiation_date": "20180622", "center_classification_date": "20180703", "termination_date": "20230322", "report_date": "20180711", "code_info": "Batch B4276A EXP 03/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90257", "recalling_firm": "US Specialty Formulations LLC", "address_1": "1401 S Albert St", "address_2": "", "postal_code": "18103-4141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to medical facilities and a physician's office Nationwide in the USA.", "recall_number": "D-0987-2022", "product_description": "B-Complex + Chromic Chloride (Choline Chloride 3%, Inositol 3%, Pyridoxine HCl 2%, Niacinamide 2%, Thiamine HCl 2%,  Chlorobutanol 0.5%, Riboflavin 0.05%, Chromic Chloride 0.003%), 30 mL Multi-Dose Vial, packaged in 2 x 30 mL Multi-Dose Vials per carton, US Specialty Formulations, LLC, 116 Research Drive, Bethlehem, PA  18015, P/N: 234-15523", "product_quantity": "1992 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220524", "center_classification_date": "20220606", "termination_date": "20240617", "report_date": "20220615", "code_info": "Lot #:  02RP1507A, exp. date 30-Jun-22; 02RP1512A, exp. date 30-Sep-22; 02RP1514A, exp. date 31-Nov-22; 02RP1515A, exp. date 31-Dec-22", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA011719"], "brand_name": ["METHOTREXATE"], "generic_name": ["METHOTREXATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-350", "61703-408"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["METHOTREXATE SODIUM"], "rxcui": ["1655956", "1946772"], "spl_id": ["95b8b8da-da4e-4bba-9038-3cf65f3d5c1a"], "spl_set_id": ["0d63ba29-b692-41b4-87e8-351265c8273f"], "package_ndc": ["61703-350-37", "61703-350-38", "61703-408-41"], "is_original_packager": [true], "unii": ["3IG1E710ZN"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0553-2021", "product_description": "Methotrexate Injection, USP 50 mg/2mL (25 mg/mL) 5 x 2mL Single-Dose Vials, Sterile, Rx Only, Distributed by Hospira, Inc. Lake Forest, IL 60045. NDC 61703-350-38.", "product_quantity": "341 vials", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "H074437AA"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80538", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States, including Hawaii and Puerto Rico", "recall_number": "D-0988-2018", "product_description": "Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054", "product_quantity": "15,347 90-count bottles, 8,378  1000-count bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180716", "center_classification_date": "20180724", "report_date": "20180801", "code_info": "NDC 0591-2169-19  Lot Numbers:  1177880A, 1220831A, 1263941A    NDC 0591-2169-10  1175922M, 1220826M, 1236294M, 1240427M, 1270616A"}, {"status": "Terminated", "city": "Winter Park", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70317", "recalling_firm": "Anabolic Science Labs, LLC", "address_1": "900 S Kentucky Ave", "address_2": "N/A", "postal_code": "32789-4751", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "US Nationwide and Singapore", "recall_number": "D-0986-2015", "product_description": "HALO-70 MEGA MASS BUILDER (4-chloro-17a-methyl-androst-1,4-diene-3b,17b-diol 35mg), Capsules, 60 count bottle, Manufactured for: Wyked Labs LLC, Winter Park, FL 32789", "product_quantity": "515 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA  - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.", "recall_initiation_date": "20141212", "center_classification_date": "20150505", "termination_date": "20170208", "report_date": "20150513", "code_info": "All lots"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "185 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;    05072015@31, 7/6/2015; 03232015@11, 5/22/2015; 03302015@44, 5/29/2015; 03272015@16, 5/26/2015; 04222015@81, 6/1/2015; 04032015@15, 6/2/2015; 04142015@9, 6/13/2015; 04232015@11, 6/22/2015; 04272015@42, 6/26/2015; 04292015@86, 6/28/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Sermorelin/GHRP6 1000/1000 mcg/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, DO NOT SHAKE, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1631-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0066-2020", "product_description": "Labetalol HCl 5 mg/mL 20 mg/4 mL (5 mg/mL) 4 mL Fill in a 6 mL Single Dose Syringe, Rx only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676419", "product_quantity": "6405 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1016-2016", "product_description": "TRI-MIX # 1, packaged in 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 02292016:67@10, Exp. 05/29/2016; Lot #: 03022016:   98@43, Exp.05/31/2016; Lot #: 03162016:25@32, Exp. 06/14/2016; Lot #: 03302016:36@36, Exp.06/30/2016"}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075356"], "brand_name": ["PAROXETINE"], "generic_name": ["PAROXETINE HYDROCHLORIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0083", "60505-0097", "60505-0084", "60505-0101"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PAROXETINE HYDROCHLORIDE ANHYDROUS"], "rxcui": ["1738483", "1738495", "1738503", "1738511"], "spl_id": ["9cde2ef4-fd50-ed21-0628-cb6cd8a6153f"], "spl_set_id": ["08320ea3-8f93-6f04-5d1c-f69af3eb5a81"], "package_ndc": ["60505-0097-1", "60505-0097-9", "60505-0097-2", "60505-0097-4", "60505-0097-7", "60505-0097-5", "60505-0083-1", "60505-0083-9", "60505-0083-2", "60505-0083-4", "60505-0083-0", "60505-0083-5", "60505-0084-1", "60505-0084-9", "60505-0084-2", "60505-0084-4", "60505-0084-5", "60505-0101-1", "60505-0101-9", "60505-0101-2", "60505-0101-4", "60505-0101-5", "60505-0101-7"], "is_original_packager": [true], "upc": ["0360505010110", "0360505008414", "0360505009718", "0360505008315"], "unii": ["3I3T11UD2S"]}, "product_type": "Drugs", "event_id": "93353", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0119-2024", "product_description": "Paroxetine Hydrochloride Tablets USP, RX only, 10 mg   a) 30-count bottle, NDC#: 60505-0097-1; b) 100-count bottle, NDC#: 60505-0097-2; c) 1000-count bottle, NDC#: 60505-0097-4, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.", "product_quantity": "34,392", "reason_for_recall": "Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine", "recall_initiation_date": "20231101", "center_classification_date": "20231127", "report_date": "20231206", "code_info": "Lot numbers: a)100 count bottle: RV2376, RV2377; b) 1000 count bottle: RV2379, RV2380; c) 30 count bottle: RV2375; Exp. 08/2024", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; CILOSTAZOL Tablet, 100 mg may be potentially mislabeled as    DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: AD65475_1, EXP: 5/28/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "CILOSTAZOL Tablet, 100 mg has the following code    Pedigree: AD65475_4, EXP: 5/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CILOSTAZOL Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 60505252201", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-660-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0825-2023", "product_description": "Lorazepam Injection, USP  2 mg/mL vial, 1 mL vials, Rx Only, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1144-2020", "product_description": "Metabolic Booster. 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0464-2022", "product_description": "Nasal & Sinus Decongestant (phenylephrine HCl 5mg) 2 tablets per packet, Mfd. for Cintas First Aid & Safety, Mason OH 45040", "product_quantity": "3,508,200 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9491, AK9496, Exp. Date 02/2022; K9817, Exp. Date 09/2022"}, {"status": "Completed", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203071"], "brand_name": ["IRBESARTAN"], "generic_name": ["IRBESARTAN"], "manufacturer_name": ["Solco Healthcare U.S., LLC"], "product_ndc": ["43547-374", "43547-375", "43547-376"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IRBESARTAN"], "rxcui": ["200094", "200095", "200096"], "spl_id": ["066a9a03-3688-4369-b57f-dcc0a209f204"], "spl_set_id": ["6916c617-92d2-44f5-b968-6267517a2ce6"], "package_ndc": ["43547-374-03", "43547-374-09", "43547-374-50", "43547-375-03", "43547-375-09", "43547-375-50", "43547-376-03", "43547-376-09", "43547-376-50"], "is_original_packager": [true], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "81910", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "700 Atrium Dr", "address_2": "N/A", "postal_code": "08873-4107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0409-2019", "product_description": "Irbesartan Tablets 300 mg 90 count  Rx only    Manufactured by: Zhejiang Huahai Pharmaceutical Co., Xunqiao, Linhai, Zhejiang  317024 China     Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512   NDC 43547-376-09", "product_quantity": "19800 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20190118", "center_classification_date": "20190127", "report_date": "20190206", "code_info": "331B18009"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0203-2023", "product_description": "Edetate Calcium Disodium 400MG/ML (30ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221013@15", "more_code_info": ""}, {"status": "Completed", "city": "Jenison", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "85854", "recalling_firm": "MICHIGAN HERBAL REMEDIES", "address_1": "904 Chicago Dr", "address_2": "", "postal_code": "49428-9351", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide via internet sales,retailers and distributors in the USA", "recall_number": "D-1462-2020", "product_description": "Herbzeedy, Hemp Oil Full Spectrum, Natural, 500 MG CBD, 1 FL OZ (30 ML) bottles, Distributed by: Herbzeedy, Statesboro, GA", "product_quantity": "134 bottles", "reason_for_recall": "Chemical contamination: product contains elevated levels of undeclared lead.", "recall_initiation_date": "20200618", "center_classification_date": "20200804", "report_date": "20200812", "code_info": "FG003122, FG003123", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090935"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Rising Health, LLC"], "product_ndc": ["57237-119", "57237-120", "57237-121", "57237-122", "57237-123", "57237-124", "57237-125", "57237-126", "57237-127"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["bab28da8-ce52-4caf-a5ef-8fa777aca739"], "spl_set_id": ["8373fced-93fe-44c6-93d9-8f21c6599f65"], "package_ndc": ["57237-119-01", "57237-119-99", "57237-119-90", "57237-120-99", "57237-120-90", "57237-120-01", "57237-121-99", "57237-121-90", "57237-121-01", "57237-122-99", "57237-122-90", "57237-122-01", "57237-123-99", "57237-123-90", "57237-123-01", "57237-124-99", "57237-124-90", "57237-124-01", "57237-125-99", "57237-125-90", "57237-125-01", "57237-126-99", "57237-126-90", "57237-126-01", "57237-127-99", "57237-127-90", "57237-127-01"], "is_original_packager": [true], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "91713", "recalling_firm": "RISING PHARMACEUTICALS", "address_1": "2 Tower Center Blvd", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.", "recall_number": "D-0348-2023", "product_description": "Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01", "product_quantity": "12,216 bottles (100 count each)", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20230215", "center_classification_date": "20230223", "termination_date": "20240614", "report_date": "20230301", "code_info": "Batch #: NB101596, Exp. 04/30/2023"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 22.5/0.83 mg/15 mcg/mL; 5 mL  unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0699-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 1 mg may be potentially mislabel as    MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: W003117, EXP: 6/13/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "PRAMIPEXOLE DI-HCL Tablet, 1 mg has the following code    Pedigree: W003150, EXP: 6/13/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PRAMIPEXOLE DI-HCL Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058701", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-522-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83101", "recalling_firm": "Preferred Pharmaceuticals, Inc", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distribution was made to CA and FL.", "recall_number": "D-1410-2019", "product_description": "Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP 100mg, 118mL (4oz) bottle, Manufactured for Preferred Pharmaceuticals, Inc., Anaheim, CA 92807 by Major Pharmaceuticals, Livonia, MI 48152, NDC 68788-0841-01", "product_quantity": "192 4 oz bottles", "reason_for_recall": "CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190610", "center_classification_date": "20190620", "termination_date": "20230403", "report_date": "20190626", "code_info": "Lot: J0218L, Batch: 10021812, Exp. 02/2020; Lot: L2718D, Batch numbers from consecutively from  L2718D001 to L2718D096, Exp. 07/2020"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0434-2019", "product_description": "Prednisolone and Gatifloxacin and Ketorolac Ophthalmic Solution 1%/0.5%/0.5%, Combo Drops: 3 mL Rx Only, Compounded Prescription, Promise Pharmacy 31818 US Hwy 19N, Palm Harbor FL 34684", "product_quantity": "250 3 ml bottles", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 09262018@5 BUD: 1/15/2019; 10092018@1 BUD: 1/25/2019; 11052018@1 BUD: 2/21/2019"}, {"status": "Ongoing", "city": "North Bergen", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M017"], "brand_name": ["DERMASARRA"], "generic_name": ["OTC TOPICAL ANALGESIC DRUG PRODUCTS"], "manufacturer_name": ["DERMARITE INDUSTRIES, LLC"], "product_ndc": ["61924-189"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["CAMPHOR (NATURAL)"], "rxcui": ["2059052"], "spl_id": ["28880b59-b008-e343-e063-6394a90a1844"], "spl_set_id": ["1fad8650-8bd6-4711-9121-b9f6ff8bdf6b"], "package_ndc": ["61924-189-08"], "is_original_packager": [true], "upc": ["0714196188083"], "unii": ["N20HL7Q941"]}, "product_type": "Drugs", "event_id": "97277", "recalling_firm": "DermaRite Industries, LLC", "address_1": "7777 W Side Ave", "address_2": "N/A", "postal_code": "07047-6436", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0611-2025", "product_description": "DermaSarra, External Analgesic, (Camphor 0.5%)  222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08", "product_quantity": "249 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.", "recall_initiation_date": "20250717", "center_classification_date": "20250902", "report_date": "20250910", "code_info": "Lot #: 40187.2, Exp. Date 2/2026"}, {"country": "United States", "city": "Lake Mary", "address_1": "550 Technology Park Ste 1008", "reason_for_recall": "Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this  compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "", "product_quantity": "380 vials (5 mL and 10 mL vials)", "code_info": "All Lots", "center_classification_date": "20130423", "distribution_pattern": "CO, GA, MI, and Puerto Rico", "state": "FL", "product_description": "TriMix Standartd (PGE Stock Sol'n) Injectable   Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746", "report_date": "20130501", "classification": "Class II", "openfda": {}, "recalling_firm": "Axium Healthcare Pharmacy dba Balanced Solutions Compounding", "recall_number": "D-270-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "64957", "termination_date": "20170419", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "32746-7131", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]